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1. Introduction 
Physicochemical data supporting the great analogy 
between ovine and bovine growth hormones has been 
previously reviewed [l] . The close homology in their 
primary structures was first indicated by very similar 
peptide maps [2] which were subsequently used by 
Seavey et al. [3] to pinpoint the only differences 
between them as located in a single tryptic peptide. 
The complete sequence of a cyanogen bromide frag- 
ment in ovine growth hormone, reported by 
Ferna’ndez et al. [4], was found identical to the cor- 
responding fragment in bovine growth hormone, ex- 
cept for two replacements which were the same as 
those occurring in the tryptic peptide of Seavey et al. 
[3]. Other analogies between ovine and bovine growth 
hormones are: identical amino acid sequence and 
microheterogeneity in their N-terminal peptides; 
identical sequence of the last 13 amino acids in the 
chain and similar distribution of the methionyl residues 
in the molecule [I]. 
The chemical study of ovine growth hormone has 
reached a point in our laboratory where it is possible 
to express its complete amino acid sequence by a 
unique combination of tryptic, chymotryptic and 
peptic peptides, plus information mentioned before 
[ 1,2,4] . The amino acid sequence of a number of 
peptides is based on homology with bovine growth 
hormone. 
2. Materials and methods 
These were as indicated in [ 1,2,4], unless stated 
North-Holland Publishing Company - Amsterdam 
otherwise. The compositions of the solvents used for 
paper chromatography were as follows, solvent 1: 
butan-1-ol-acetic acid-water (4:1:5, by vol); solvent 
2: butan-1-ol-acetic acid-water-pyridine (5: 1:4:3.3, 
by vol). 
2.1. Tryptic peptide maps 
Digestions were carried out with native or oxidized 
hormone. The chromatography was performed for 18 hr 
with solvent 1 and the electrophoresis lasted 1 hr 
at 50 V/cm. The peptide spots, located by reaction 
with ninhydrin, were eluted with 5.7 M hydrochloric 
acid or 5% acetic acid and the solutions used for 
amino acid composition or N-terminal determinations, 
respectively. 
2.2. Isolation of tryptophan-containing peptides 
The citraconylated [6] hormone was digested with 
trypsin and then submitted to electrophoresis at pH 
6.45 for 1 hr, at 50 V/cm. The band in which the 
digest was originally applied was cut and stitched to a 
sheet of Whatman 3MM paper. By descending chroma- 
tography during 24 hr with solvent 1, it was possible 
to isolate in pure condition peptide TCa (table 1). 
Another tryptophan-containing peptide was isolated 
by the following procedure: a tryptic digest of native 
hormone dissolved in 20% formic acid was filtered 
through a Sephadex G-50 column (2.6 X 90 cm), 
and eluted at 15 ml per hour with the same solvent. 
The Ehrlich-positive material appearing in the void 
volume was collected and digested again with trypsin 
in the presence of 0.1% sodium dodecyl sulphate. 
From this second digest it was possible to isolate in 
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Table 2. 
Amino acid composition of chymotrypic peptides from ovine growth hormone. 
Amino Peptide 
acid 
cl c2 c3 c7 c8 clO-ll cll-13 c13 c17 c18 c19 c24 c25 C26a C26b c29-30 
l/2 cys 0.7 0.9 
Asp 1.0 2.2 1.2 1.0 1.1 1.0 3.6 1.0 
Thr 1.2 2.1 1.9 1.0 1.0 1.1 
Ser 0.8 0.9 1.0 1.5 1.0 1.0 1.1 1.2 0.6 
GlU 1.0 2.1 1.1 5.4 3.5 2.9 
Pro 1.2 1.1 2.3 2.2 
GUY 0.9 1.1 1.3 0.8 1.1 1.0 
Ala 2.0 1.9 1.0 2.0 0.9 1.1 
Val 1.0 1.0 0.9 1.0 
Met 1.0 0.7 1.3 
Be 0.8 0.8 0.9 0.8 
Leu 1.0 1.1 1.1 3.3 3.0 1.1 3.4 2.3 2.0 0.8 
Tyr 0.9 0.8 0.7 0.9 
Phe 0.9 1.1 1.0 0.9 1.0 
LYS 1.5 1.0 1.5 1.1 
Arg 1.0 0.7 0.8 0.8 0.8 
Uncorrected values obtained after 20 hr of hydrolysis, expressed as residues per mole of peotide. 
pure condition peptide T7_a (table 1) by the successive 
application of high voltage electrophoresis at pH 6.45 
and chromatography with solvent 2 performed at 
right angles to the direction of the electrophoretic 
run. 
2.3. Chymotryptic peptides 
Were obtained and fractionated by ion-exchange 
chromatography, as described for bovine growth 
hormone [S] . Further purification of the isolated 
fractions was achieved by electrophoresis at pH 6.45 
and two-dimensional chromatography with solvents 
1 and 2. 
2.4. Peptic peptides 
The majority of these were obtained from a pep- 
tic digest of cyanogen bromide fragment 1 [ 11 sub- 
mitted to high voltage electrophoresis at pH 6.45 and 
chromatography with solvent 2. Peptides P25a and 
P25b were obtained from a peptic digest of native 
hormone filtered through a Sephadex G-50 column 
as indicated by Zakin et al. [7] . The fractions con- 
taining the disultide bridge not C-terminal, were re- 
duced and carboxymethylated [8], filtered through 
a Sephadex G-25 column and submitted to partial 
acid hydrolysis [S] . By chromatography of the 
hydrolysate on a sulphonic acid resin [4] the pep- 
tides P,s, and P25b were obtained in pure condition. 
2.5. ho&ion of cystine-containing peptides 
A tryptic digest of the hormone was fractionated 
on Sephadex G-50 as indicated before for the isola- 
tion of tryptophan-containing peptides. The presence 
of half-cystine was detected by amino acid analysis 
after oxidation of the sample [5] . Those fractions 
whose amino acid compostion indicated that their 
half-cystine did not belong to the C-terminal di- 
sulfide bridge were pooled, reduced and blocked with 
ethylenimine [7]. The mixture was resolved on a 
Sephadex G-25 column (1.4 X 90 cm) equilibrated 
and eluted with 20% formic acid. The larger of the two 
peptides isolated was redigested with trypsin and the 
mixture purified by electrophoresis at pH 6.45 and 
paper chromatography with solvent 1. 
2.6. Nomenclature 
Peptides derived from tryptic, chymotryptic 
and peptic hydrolysates bear the prefx T, C or P, 
respectively, and are numbered in the order in 
which they occur in the sequence. Peptides derived 
from tryptic digestion of aminoethyl or citraconyl 
hormone bear the prefti TA or TC, respectively. 
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BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
BGH 
OGH 
in 7n 
Ala-Phe-Pro-Ala-Met-Ser-Leu-Ser-Gly-Leu-Phe-Ala-Asn-Ala-Val-Leu-Arg-Ala-~ln-His-Leu- 
Ala-Phe-Pro-Ala-Met-Ser-Leu(Ser,Gly,Leu)Phe(Ala,Asn)Ala-Val-Leu-Arq-Pla(Glx,His,Leu, 
c---------TI~--------------II+T~~-I~ 
t > 
-c 1 Ik---c7-Ik-----c3---_1 
I----P33------1 
I_________________, 
I______________, 
30 4n 
His-Gln-Leu-Ala-Ala-Asp-Thr-Phe-Lys-Glu-Phe-Glu-Arq-Thr-Tyr-Ile-Glu-Pro-Gly-Gln-Arq- 
His,Glx,Leu,Ala,Ala,Asp,Thr,Phe)Lys-Glu-Phe-Glu-Arg-Thr-Tyr(Ile,Glx,Pro,~ly,Glx)Arg- 
-TT IWT3--I -T4- 
T 2-3 
t-d.7' l-CC------ 
-P4 
+--P4b- 
50 r 
to 162 6n 
Tyr-Ser-Ile-Gln-Asn-Thr-Gln-Val-Ala-Phe-Cys-Phe-Ser-Glu-Thr-Ile-Pro-Ala-Pro-Thr-Gly- 
(:yr,Ser,Ile,Glx,Asx~~h;~Glx,Val,Ala,Phe)Cys-Phe-Ser(Glu,Thr,Ile,P~,Ala,Pro,Thr)Gly- 
I_TA5- 
--I a C 10-11 I 
t : 
70 80 
Lys-Asn-Gl~-Ala-Gln-Glu-Lys-Ser-Asp-Leu-Glu-Leu-Leu-Arq-Ile-Ser-Leu-Leu-Leu-Ile-Ser- 
Lys-Asx-Glx(Ala,Glx,Glx)Lys-Ser-Asx-Leu-Glu-Leu-Leu-Arq(Ile,Ser,Leu,Leu,Leu,Ile,Ser, 
--Iv-T+ I 
I : : : 
~cl3- 
- c 11-13 I 
I-P8b-A 
T 7-8 - 
90 100 
Glu-Trp-Leu-Glx-Pro-Gly-Phe-Leu-Arg-Val-Phe-Thr-Asn-Ser-Leu-Val-Phe-Gly-Th~-Ser-Asp- 
Glx,Trp,Leu,Glx,Pro,Gly,Phe,Leu)Arg-Val-Phe(Thr,Asn,Ser,Leu,Val,Phe,Gly,Thr,Ser,Asp) 
-TC 8 i--T9 
110 120 Leu 
A~g-Val-Tyr-Glu-Lys-Leu-Lys-Asp-Leu-Glu-Glu-Gly-Ile-Leu-Ala-Leu-~et-Ar9-Glu-Val-Glu- 
Arg-Val-Tyr-Glu-Lys-Leu-Lys-Asp-Leu-Glu-Glu-Gly-Ile-Leu(Ala,Leu)Met-Arg-~lu-Leu-~lu- 
-1 t--T 10---l 
I-T 11-12 
-------_1~c 19m 
I 
k________________ 
130 140 
Asp-Gly-Thr-Pro-Arg-Ala-Gly-Gln-I1e-Leu-Lys-Gln-Thr-Tyr-Asp-Lys-Phe-Asp-Thr-Asn-Met- 
Asp-Val-Thr-Pro-Arg-Ala-Gly-Gln-Ile-Leu-Lys-Gln-Thr-Tyr-Asp-Lys-Phe-Asp-Thr-Asn-Met- 
k : ________________________________________~~__~_~__~___~___~_~~_~~~___~~~~~~~~______, 
to 53 
150 160 1 
Arg-Ser-Asp-Asp-Ala-Leu-Leu-Lys-Asn-Tyr-Gly-Leu-Leu-Ser-Cys-Phe-A*9-Lys-Asn-Leu-Hi~- 
Arg-Ser(Asp,Asp,Ala)Leu-Leu-Lys-Asn-Tyr(Gly,Leu)Leu-Ser-Cys-Phe-Arq-Lys-Asn(Leu His) 
~T17---------1~TT8--------_( l-+T2fJ- 
tp T 18-19 B 
_ TA 1Aa + C-T 19-20 - 
-C 74 ______( + C 25 --it-C 26a -I WC 26h --i 
I-P 22a -----I b P 25a __( I- 
f 
to 187 to 179 
170 180 'I 
Lys-Thr-Glu-Thr-Tyr-Leu-Arg-Val-Met-Lys-Cys-Arq-Arg-Phe-Gly-Glu-Ala-Ser-Cys-Ala-Phe 
Lys-Thr(Glu.Thr)Tyr-Leu-Arq-Val-Met-Lys-Cys-Arq-Arq-Phe-Gly-Glu-Ala-Ser-Cys-Ala-Phe 
-1 t+T 21 -it-T22-l 
--i 
t- c 29-30 -I 
-P 25b -1 
k_____________________________________________l 
Fig. 1. Amino acid sequence of the ovine growth hormone molecule compared to that of bovine growth hormone [ 91. The full 
line segments indicate tryptic (T, TA and TC), chymotryptic (C) and peptic (P) peptides. Dotted line segments correspond to 
cyanogen bromide fragments [ 1,4] .-+Steps of Edman degradations. 
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Table 3 4. Discussion 
Amino acid composition of peptic peptides from ovine 
growth hormone. All the information collected in tables 1, 2 and 3 is 
organized in fig. 1 to give a unique sequence of amino 
acids for the polypeptide chain of ovine growth hor- 
mone. Only the necessary peptides have been shown, 
although many more were studied but gave redundant 
information. The sequence shown incorporates also 
the structures, previously published, of the N- and 
C-terminal regions [I] and of a cyanogen bromide 
fragment [4] ; in other sections of the chain besides 
these, the sequence has been established by the usual 
methods [ 51 or by considering the specificity of 
action of the proteolytic enzymes and the overlapping 
of peptides. The state of amidation of glutamyl and 
aspartyl residues could be decided, in some cases, 
from the electrophoretic mobility of the correspond- 
ing peptides. 
Amino Peptide 
acid 
P3 P4 ‘4b ‘8b ‘22a 
l/2 cys 
Asp 1.2 0.9 1.2 2.3 
ThI 1.2 1.1 
Ser 1.3 
Glu 1.9 1.0 
Ala 1.9 3.2 1.8 1.0 
Val 1.0 
Leu 1.2 1.9 0.8 2.1 1.2 
TYI 
Phe 1.0 
Lys 
His 2.1 
kg 0.8 0.8 
‘25a ‘25b 
1.0 
1.9 
0.8 
1.1 
2.1 
0.9 
0.9 
1.0 1.0 
1.1 
1.1 
Uncorrected values obtained ater 20 hr of hydrolysis, ex- 
pressed as residues per mole of peptide. 
3. Results 
3.1. Tryp tic pep tides 
The amino acid compositions of the peptides 
studied are given in table 1. The assumed integral 
number of amino acid residues in each peptide is not 
shown but the following rule was applied: any frac- 
tion below 0.5 was considered 0 residue; any frac- 
tion equal or above 0.5 was considered 1 residue. 
3.2. Chymotryptic peptid&s 
The pattern of elution of these peptides from the 
ion-exchange column was almost identical to that 
obtained with the chymotryptic digest of bovine 
growth hormone [9]. The amino acid composition of 
all selected peptides is given in table 2. 
3.3. Peptic peptides 
Table 3 summarizes the analytical data correspond- 
ing to these peptides. 
3.4. Disulfide bridge not C-terminal 
The mixture resolved on the Sephadex G-25 column, 
as indicated in sect.2.5, contained the peptides origi- 
nally joined by a disulfide bridge. These are the pep- 
tides indicated in table 1 as TA,,, TA,, and TA,,,. 
Although the procedure applied in assembling the 
ovine growth hormone molecule by partial homology 
with bovine growth hormone forces a cautiorls inter- 
pretation of the results, the amount of absolute in- 
formation incorporated gives assurance that the belief 
of near identity in the covalent structures of both 
hormones is solidly based. 
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